foto london banner.jpg

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Advanced therapies: Gaining market access in a cha...

Tune in to the final session in Phacilitate and Biotech and Money's advance...

Read More

PhoreMost raises £11m Series A round to progress t...

Key learnings: PhoreMost completed its Series A round in May 2018, with a t...

Read More

Infographic: Life sciences in the Nordics

In 2017, almost $2.2 billion was raised by Scandinavian life science compan...

Read More

Medius Deal Watch May 2018

This month’s top deals are noticeably in the category of acquisitions rathe...

Read More

What makes for a partner of choice in life science...

Medius Associates publishes a monthly report, Medius Deal Watch, that inclu...

Read More

The talent challenge in life sciences

A disconcerting 59% of investor respondents consider under one quarter of t...

Read More

Five misconceptions about whistleblowing systems p...

Would you like to be able to identify risk - whether it be reputational, fi...

Read More

Aparito applies remote patient monitoring tech to ...

Key learnings: Wales-based digital health company Aparito utilises wearable...

Read More

Data privacy regulation and the advance of new tec...

If you were not previously aware of the General Data Protection Regulation ...

Read More

How will Brexit impact the UK's life sciences indu...

In May 2018, the UK government published its response to the House of Commo...

Read More

What are the obstacles to securing investment in l...

More than one third (35%) of investor respondents feel that under a quarter...

Read More

Cognetivity’s AI-driven cognitive test seeks to ad...

Key learnings: Cognetivity Neurosciences was named joint winner in the Inno...

Read More

Add Your Response